300482 万孚生物
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.19311.00731.10520.48125.038
总资产报酬率 ROA (%)5.7228.07821.45813.84917.494
投入资产回报率 ROIC (%)6.2619.13925.31016.72321.829

边际利润分析
销售毛利率 (%)64.34262.61151.82458.46369.022
营业利润率 (%)25.85119.86124.07820.58626.330
息税前利润/营业总收入 (%)25.36419.32624.00921.70226.999
净利润/营业总收入 (%)22.74717.62920.95118.82121.944

收益指标分析
经营活动净收益/利润总额(%)96.45886.96398.97188.859109.869
价值变动净收益/利润总额(%)3.5438.4885.3198.5264.403
营业外收支净额/利润总额(%)-0.463-1.549-0.235-1.677-1.253

偿债能力分析
流动比率 (X)7.4916.6772.9363.2662.861
速动比率 (X)6.6485.9522.5862.7782.387
资产负债率 (%)17.88620.04827.98827.8380.305
带息债务/全部投入资本 (%)9.81211.76218.14415.82518.987
股东权益/带息债务 (%)896.524730.796441.986524.162422.286
股东权益/负债合计 (%)451.110390.286246.313248.056216.562
利息保障倍数 (X)-68.893-83.428-1,954.01314.91027.132

营运能力分析
应收账款周转天数 (天)81.39874.11032.90741.11144.055
存货周转天数 (天)122.381130.82851.71398.364124.084